Boston Scientific , Guidant Settle Patent Suits Over Drug-Coated Stents
The two companies have sued each other for patent infringement over coronary stents, coronary stent delivery systems and dilatation catheters.
Under the settlement agreement, all pending disputes between the companies will be immediately dismissed. In addition, the companies have agreed to cross license patents in certain specified technology areas.
The lucrative market for drug-coated stents has become increasingly...
To view the full article, register now.